These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20715715)

  • 21. Biofilm-related infections in ophthalmology.
    Elder MJ; Stapleton F; Evans E; Dart JK
    Eye (Lond); 1995; 9 ( Pt 1)():102-9. PubMed ID: 7713236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of the Qoustic Wound Therapy System against planktonic and biofilm bacteria.
    Karau MJ; Piper KE; Steckelberg JM; Kavros SJ; Patel R
    Adv Skin Wound Care; 2010 Jul; 23(7):316-20. PubMed ID: 20562540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival strategies of infectious biofilms.
    Fux CA; Costerton JW; Stewart PS; Stoodley P
    Trends Microbiol; 2005 Jan; 13(1):34-40. PubMed ID: 15639630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression in Pseudomonas aeruginosa biofilms.
    Whiteley M; Bangera MG; Bumgarner RE; Parsek MR; Teitzel GM; Lory S; Greenberg EP
    Nature; 2001 Oct; 413(6858):860-4. PubMed ID: 11677611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance.
    Landry RM; An D; Hupp JT; Singh PK; Parsek MR
    Mol Microbiol; 2006 Jan; 59(1):142-51. PubMed ID: 16359324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management.
    McCann MT; Gilmore BF; Gorman SP
    J Pharm Pharmacol; 2008 Dec; 60(12):1551-71. PubMed ID: 19000360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-biofilm activity of sub-inhibitory povidone-iodine concentrations against Staphylococcus epidermidis and Staphylococcus aureus.
    Oduwole KO; Glynn AA; Molony DC; Murray D; Rowe S; Holland LM; McCormack DJ; O'Gara JP
    J Orthop Res; 2010 Sep; 28(9):1252-6. PubMed ID: 20187117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foreign body infections due to Staphylococcus epidermidis.
    Uçkay I; Pittet D; Vaudaux P; Sax H; Lew D; Waldvogel F
    Ann Med; 2009; 41(2):109-19. PubMed ID: 18720093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan-based rechargeable long-term antimicrobial and biofilm-controlling systems.
    Cao Z; Sun Y
    J Biomed Mater Res A; 2009 Jun; 89(4):960-7. PubMed ID: 18470925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections?
    Lönn-Stensrud J; Landin MA; Benneche T; Petersen FC; Scheie AA
    J Antimicrob Chemother; 2009 Feb; 63(2):309-16. PubMed ID: 19098295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving concepts in biofilm infections.
    Hall-Stoodley L; Stoodley P
    Cell Microbiol; 2009 Jul; 11(7):1034-43. PubMed ID: 19374653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro resistance to bacterial biofilm formation on coated fluoroplastic tympanostomy tubes.
    Berry JA; Biedlingmaier JF; Whelan PJ
    Otolaryngol Head Neck Surg; 2000 Sep; 123(3):246-51. PubMed ID: 10964299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ovotransferrin, protamine sulfate and EDTA combination on biofilm formation by catheter-associated bacteria.
    Yakandawala N; Gawande PV; Lovetri K; Madhyastha S
    J Appl Microbiol; 2007 Mar; 102(3):722-7. PubMed ID: 17309621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
    Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
    J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms.
    Van Acker H; Van Dijck P; Coenye T
    Trends Microbiol; 2014 Jun; 22(6):326-33. PubMed ID: 24598086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical significance and new therapeutical strategies for biofilm associated infections.
    Lazăr V; Chifiriuc MC
    Roum Arch Microbiol Immunol; 2010; 69(3):125-38. PubMed ID: 21434589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial resistance in biofilm-associated bacteria.
    Venkatesan N; Perumal G; Doble M
    Future Microbiol; 2015; 10(11):1743-50. PubMed ID: 26517598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biofilm infections, their resilience to therapy and innovative treatment strategies.
    Römling U; Balsalobre C
    J Intern Med; 2012 Dec; 272(6):541-61. PubMed ID: 23025745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms.
    Percival SL; Hill KE; Malic S; Thomas DW; Williams DW
    Wound Repair Regen; 2011; 19(1):1-9. PubMed ID: 21235682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biofilm-related disease.
    Del Pozo JL
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):51-65. PubMed ID: 29235402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.